Key Points

Nationally, for the year 2024:

• The national standardized participation rate for the target population was 60.9%, up since the implementation of the PNDO (+9.7 percentage points compared to 2017) but below the acceptable European threshold of 70%.

• Participation is higher than in 2023 across all age groups, including among those aged 60–65 (an increase of 4.3 percentage points).

• Four departments meet the European acceptable threshold (Finistère, Morbihan, Isère, Hautes-Alpes), but significant regional disparities remain. In mainland France, more than 25 percentage points separate the department with the highest participation rate (Hautes-Alpes at 73.5%) and the one with the lowest rate (Seine-Saint-Denis at 45.7%). For the overseas departments and regions (DROM), there is a 48.4 percentage point gap between Réunion (65.8%) and Mayotte (17.4%).

• 8.8% of screenings were conducted via invitation-based screening in 2024, representing a decrease of 4.3 percentage points compared to 2023.

• Among women aged 30 to 65, the uptake of the HPV test continues to rise: 90.5% of screenings in this age group were performed using this test (versus 30.7% in 2020).